PT - JOURNAL ARTICLE AU - Zubir, M Zulfakhar AU - Noor, A Azimatun AU - Rizal, AM Mohd AU - Harith, A Aziz AU - Abas, M Ihsannuddin AU - Zakaria, Zuriyati AU - A.Bakar, Anwar Fazal TI - Approach in Inputs & Outputs Selection of Data Envelopment Analysis (DEA) Efficiency Measurement in Hospital: A Systematic Review AID - 10.1101/2023.10.18.23297223 DP - 2023 Jan 01 TA - medRxiv PG - 2023.10.18.23297223 4099 - http://medrxiv.org/content/early/2023/10/19/2023.10.18.23297223.short 4100 - http://medrxiv.org/content/early/2023/10/19/2023.10.18.23297223.full AB - Data Envelopment Analysis (DEA) has been employed as a performance evaluation tool in the evaluation of efficiency and productivity in numerous fields. This includes hospitals in particular as well as the broad healthcare industry. This review examines 89 papers that discuss the use of DEA in hospitals, paying particular attention to approaches for choosing inputs and outputs as well as the most recent developments in DEA studies. English articles with empirical data from year 2014-2022 (Web of Science, Scopus, PubMed, ScienceDirect, Springer Link, and Google Scholar) were extracted based on PRISMA methodology. DEA Model parameters were specified based on previous studies and approaches were identified narratively. The approaches can be grouped into four: (1) Literature review, (2) Data availability, (3) Systematic method and (4) Expert judgement. The approaches were applied as one strategy either by itself or in combination with others. This review’s emphasis on approaches used in hospital may constrain its conclusions. There might be another strategy or method used to select the input and output for a DEA study in a different area or strategies based on different viewpoints. The trend for DEA application were quite similar to previous studies. There is no evidence that one model fits all DEA model parameters better than another. Based on the reviewed literature, we offer some recommendations and methodological principles for DEA studies.Competing Interest StatementThe authors have declared no competing interest.Clinical Protocols https://osf.io/nby9m Funding StatementThe author(s) received no specific funding for this work.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.Not ApplicableThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:N/AI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.Not ApplicableI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).Not ApplicableI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.Not Applicable